EW Thommes, M Kruse, M Kohli… - Human vaccines & …, 2017 - Taylor & Francis
ABSTRACT In the 2015/16 influenza season, the Canadian National Advisory Committee on Immunization (NACI) recommended vaccination with quadrivalent inactivated influenza …
IB Nwogu, M Jones, T Langley - Vaccine, 2021 - Elsevier
Abstract Background Meningococcal serogroup B (MenB) has emerged as the leading cause of invasive meningococcal disease (IMD) in several countries following the release of …
MA Nagi, C Luangsinsiri… - Expert Review of …, 2021 - Taylor & Francis
Introduction A vaccine introduction process should be systematic and transparent and take into account many factors, including cost-effectiveness evidence. This study aimed to assess …
Introduction Despite the WHO recommendation that economic evidence be considered in national vaccine recommendations, this element of decision-making has been lacking or not …
E McClymont, J Brophy, V Dubey, J Kwong… - Human Vaccines & …, 2022 - Taylor & Francis
Potential conflicts of interest in vaccine research can lead to negative consequences that undermine public trust and thereby put communities at risk. However, collaborations that …
AMC Sartori, LM Rozman, TC Decimoni… - Human Vaccines & …, 2017 - Taylor & Francis
ABSTRACT Background: In Brazil, since 2005, the Ministry of Health requires Health Economic Evaluation (HEE) of vaccines for introduction into the National Immunization …
Abstract Background and Objectives Although many systematic reviews for the human papillomavirus vaccines cost effectiveness have been published, they vary in perspectives …
This year, the global community celebrates 50 years of progress since the launch of the Expanded Programme on Immunization (now called the Essential Programme on …
Cette année, le monde célèbre 50 ans de progrès depuis le lancement du Programme élargi de vaccination, maintenant appelé le Programme essentiel de vaccination. On estime …